XML 16 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Net sales $ 41,285,000 $ 28,556,000 $ 77,192,000 $ 51,648,000
Cost of sales 5,522,000 4,359,000 10,702,000 7,480,000
Gross profit 35,763,000 24,197,000 66,490,000 44,168,000
Operating expenses:        
Selling, general and administrative 24,675,000 15,120,000 46,156,000 27,408,000
In-process research and development 5,320,000   5,320,000  
Research and development 9,633,000 6,955,000 18,575,000 14,017,000
Total operating expenses 39,628,000 22,075,000 70,051,000 41,425,000
(Loss) income from operations (3,865,000) 2,122,000 (3,561,000) 2,743,000
Other income, net        
Interest and other income 598,000 286,000 1,234,000 621,000
Interest and other expense, net (12,000) (76,000) (19,000) (178,000)
Change in fair value of stock warrant liability       43,000
Total other income, net 586,000 210,000 1,215,000 486,000
(Loss) income before taxes (3,279,000) 2,332,000 (2,346,000) 3,229,000
Provision for income taxes 22,000 0 77,000 0
Net (loss) income attributable to Glaukos Corporation stockholders $ (3,301,000) $ 2,332,000 $ (2,423,000) $ 3,229,000
Basic net (loss) income per share, attributable to Glaukos Corporation stockholders $ (0.10) $ 0.07 $ (0.07) $ 0.10
Diluted net (loss) income per share, attributable to Glaukos Corporation stockholders $ (0.10) $ 0.06 $ (0.07) $ 0.09
Weighted average shares used to compute basic net (loss) income per share attributable to Glaukos Corporation stockholders 34,322 32,652 34,234 32,477
Weighted average shares used to compute diluted net (loss) income per share attributable to Glaukos Corporation stockholders 34,322 36,182 34,234 35,975